41. T.A. Shtam, R.A. Kovalev, E.Y. Varfolomeeva, E.M. Makarov, Y.V. Kil, M.V. Filatov,
Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun.
Signal. 11(1), 88 (2013)
42. H. Choi, Y.-S. Lee, D.W. Hwang, D.S. Lee, Translational radionanomedicine: a clinical
perspective. Eur. J. Nanomed. 8(2), 71–84 (2016)
43. H. Choi, D.S. Lee, Illuminating the physiology of extracellular vesicles. Stem Cell Res. Ther.
7(1), 55 (2016)
44. S.M. Moghimi, A.C. Hunter, J.C. Murray, Long-circulating and target-specific nanoparticles:
theory to practice. Pharmacol. Rev. 53(2), 283–318 (2001)
45. S.-D. Li, L. Huang, Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm. 5(4),
496–504 (2008)
46. S. Reske, Recent advances in bone marrow scanning. Eur. J. Nucl. Med. Mol. Imaging 18(3),
203–221 (1991)
47. H. Sarin, Physiologic upper limits of pore size of different blood capillary types and another
perspective on the dual pore theory of microvascular permeability. J. Angiogenes Res. 2(1),
14 (2010)
48. M.C. Garnett, P. Kallinteri, Nanomedicines and nanotoxicology: some physiological
principles. Occup. Med. Lond. 56(5), 307–311 (2006)
49. S.J. Gould, G. Raposo, As we wait: coping with an imperfect nomenclature for extracellular
vesicles. J. Extracell. Vesicles 2(1), 20389 (2013)
50. S. El Andaloussi, I. Mäger, X.O. Breakefield, M.J. Wood, Extracellular vesicles: biology and
emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12(5), 347 (2013)
51. S. Rana, S. Yue, D. Stadel, M. Zoller, Toward tailored exosomes: the exosomal tetraspanin
web contributes to target cell selection. Int. J. Biochem. Cell Biol. 44(9), 1574–1584 (2012)
52. S. Rana, M. Zöller, Exosome target cell selection and the importance of exosomal
tetraspanins: a hypothesis. Biochem. Soc. Trans. 39(2), 559–562 (2011)
53. L. Lattanzi, M. Federico, A strategy of antigen incorporation into exosomes: comparing
cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral
virus-like particles. Vaccine 30(50), 7229–7237 (2012)
54. R.C. Lai, S.S. Tan, R.W.Y. Yeo, A.B.H. Choo, A.T. Reiner, Y. Su et al., MSC secretes at
least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
J. Extracell. Vesicles 5(1), 29828 (2016)
8 Endogenous Radionanomedicine: Biodistribution and Imaging
165
Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun.
Signal. 11(1), 88 (2013)
42. H. Choi, Y.-S. Lee, D.W. Hwang, D.S. Lee, Translational radionanomedicine: a clinical
perspective. Eur. J. Nanomed. 8(2), 71–84 (2016)
43. H. Choi, D.S. Lee, Illuminating the physiology of extracellular vesicles. Stem Cell Res. Ther.
7(1), 55 (2016)
44. S.M. Moghimi, A.C. Hunter, J.C. Murray, Long-circulating and target-specific nanoparticles:
theory to practice. Pharmacol. Rev. 53(2), 283–318 (2001)
45. S.-D. Li, L. Huang, Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm. 5(4),
496–504 (2008)
46. S. Reske, Recent advances in bone marrow scanning. Eur. J. Nucl. Med. Mol. Imaging 18(3),
203–221 (1991)
47. H. Sarin, Physiologic upper limits of pore size of different blood capillary types and another
perspective on the dual pore theory of microvascular permeability. J. Angiogenes Res. 2(1),
14 (2010)
48. M.C. Garnett, P. Kallinteri, Nanomedicines and nanotoxicology: some physiological
principles. Occup. Med. Lond. 56(5), 307–311 (2006)
49. S.J. Gould, G. Raposo, As we wait: coping with an imperfect nomenclature for extracellular
vesicles. J. Extracell. Vesicles 2(1), 20389 (2013)
50. S. El Andaloussi, I. Mäger, X.O. Breakefield, M.J. Wood, Extracellular vesicles: biology and
emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12(5), 347 (2013)
51. S. Rana, S. Yue, D. Stadel, M. Zoller, Toward tailored exosomes: the exosomal tetraspanin
web contributes to target cell selection. Int. J. Biochem. Cell Biol. 44(9), 1574–1584 (2012)
52. S. Rana, M. Zöller, Exosome target cell selection and the importance of exosomal
tetraspanins: a hypothesis. Biochem. Soc. Trans. 39(2), 559–562 (2011)
53. L. Lattanzi, M. Federico, A strategy of antigen incorporation into exosomes: comparing
cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral
virus-like particles. Vaccine 30(50), 7229–7237 (2012)
54. R.C. Lai, S.S. Tan, R.W.Y. Yeo, A.B.H. Choo, A.T. Reiner, Y. Su et al., MSC secretes at
least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
J. Extracell. Vesicles 5(1), 29828 (2016)
8 Endogenous Radionanomedicine: Biodistribution and Imaging
165